Leenders WP - Search Results

1

Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option.

Leenders WP, Küsters B, Verrijp K, Maass C, Wesseling P, Heerschap A, Ruiter D, Ryan A, de Waal R. Leenders WP, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6222-30. doi: 10.1158/1078-0432.CCR-04-0823. Clin Cancer Res. 2004. PMID: 15448011

2

Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?

Leenders WP. Leenders WP. Int J Exp Pathol. 1998 Dec;79(6):339-46. doi: 10.1046/j.1365-2613.1998.00086.x. Int J Exp Pathol. 1998. PMID: 10319015 Free PMC article. Review.

3

In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities.

Leenders W, van Altena M, Lubsen N, Ruiter D, De Waal R. Leenders W, et al. Int J Cancer. 2001 Feb 1;91(3):327-33. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1052>3.3.co;2-n. Int J Cancer. 2001. PMID: 11169955

4

Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.

Küsters B, Leenders WP, Wesseling P, Smits D, Verrijp K, Ruiter DJ, Peters JP, van Der Kogel AJ, de Waal RM. Küsters B, et al. Among authors: leenders wp. Cancer Res. 2002 Jan 15;62(2):341-5. Cancer Res. 2002. PMID: 11809675

5

Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1.

Leenders W, Lubsen N, van Altena M, Clauss M, Deckers M, Löwik C, Breier G, Ruiter D, de Waal R. Leenders W, et al. Lab Invest. 2002 Apr;82(4):473-81. doi: 10.1038/labinvest.3780440. Lab Invest. 2002. PMID: 11950904 Free article.

6

Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis.

Leenders WP, Küsters B, de Waal RM. Leenders WP, et al. Endothelium. 2002;9(2):83-7. doi: 10.1080/10623320212006. Endothelium. 2002. PMID: 12200959

7

Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.

Leenders W, Küsters B, Pikkemaat J, Wesseling P, Ruiter D, Heerschap A, Barentsz J, de Waal RM. Leenders W, et al. Int J Cancer. 2003 Jul 1;105(4):437-43. doi: 10.1002/ijc.11102. Int J Cancer. 2003. PMID: 12712432

8

Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma.

Küsters B, de Waal RM, Wesseling P, Verrijp K, Maass C, Heerschap A, Barentsz JO, Sweep F, Ruiter DJ, Leenders WP. Küsters B, et al. Among authors: leenders wp. Cancer Res. 2003 Sep 1;63(17):5408-13. Cancer Res. 2003. PMID: 14500375

9

Sprouting angiogenesis versus co-option in tumor angiogenesis.

de Waal RM, Leenders WP. de Waal RM, et al. Among authors: leenders wp. EXS. 2005;(94):65-76. doi: 10.1007/3-7643-7311-3_5. EXS. 2005. PMID: 15617471 Review. No abstract available.

10

Increased vascularization predicts favorable outcome in follicular lymphoma.

Koster A, van Krieken JH, Mackenzie MA, Schraders M, Borm GF, van der Laak JA, Leenders W, Hebeda K, Raemaekers JM. Koster A, et al. Clin Cancer Res. 2005 Jan 1;11(1):154-61. Clin Cancer Res. 2005. PMID: 15671540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters